156 related articles for article (PubMed ID: 17670832)
21. Solution structure of the pseudo-5' splice site of a retroviral splicing suppressor.
Cabello-Villegas J; Giles KE; Soto AM; Yu P; Mougin A; Beemon KL; Wang YX
RNA; 2004 Sep; 10(9):1388-98. PubMed ID: 15317975
[TBL] [Abstract][Full Text] [Related]
22. Intronic sequences and 3' splice sites control Rous sarcoma virus RNA splicing.
McNally MT; Beemon K
J Virol; 1992 Jan; 66(1):6-11. PubMed ID: 1309264
[TBL] [Abstract][Full Text] [Related]
23. A cellular protein, hnRNP H, binds to the negative regulator of splicing element from Rous sarcoma virus.
Fogel BL; McNally MT
J Biol Chem; 2000 Oct; 275(41):32371-8. PubMed ID: 10934202
[TBL] [Abstract][Full Text] [Related]
24. RNA processing control in avian retroviruses.
McNally MT
Front Biosci; 2008 May; 13():3869-83. PubMed ID: 18508481
[TBL] [Abstract][Full Text] [Related]
25. Regulation of Rous sarcoma virus RNA splicing and stability.
Arrigo S; Beemon K
Mol Cell Biol; 1988 Nov; 8(11):4858-67. PubMed ID: 2850470
[TBL] [Abstract][Full Text] [Related]
26. Characterization of Rous sarcoma virus intronic sequences that negatively regulate splicing.
McNally MT; Gontarek RR; Beemon K
Virology; 1991 Nov; 185(1):99-108. PubMed ID: 1656608
[TBL] [Abstract][Full Text] [Related]
27. Novel exploitation of a nuclear function by influenza virus: the cellular SF2/ASF splicing factor controls the amount of the essential viral M2 ion channel protein in infected cells.
Shih SR; Krug RM
EMBO J; 1996 Oct; 15(19):5415-27. PubMed ID: 8895585
[TBL] [Abstract][Full Text] [Related]
28. A suboptimal src 3' splice site is necessary for efficient replication of Rous sarcoma virus.
Zhang L; Stoltzfus CM
Virology; 1995 Feb; 206(2):1099-107. PubMed ID: 7856084
[TBL] [Abstract][Full Text] [Related]
29. A bidirectional SF2/ASF- and SRp40-dependent splicing enhancer regulates human immunodeficiency virus type 1 rev, env, vpu, and nef gene expression.
Caputi M; Freund M; Kammler S; Asang C; Schaal H
J Virol; 2004 Jun; 78(12):6517-26. PubMed ID: 15163745
[TBL] [Abstract][Full Text] [Related]
30. Overexpression of the SR proteins ASF/SF2 and SC35 influences alternative splicing in vivo in diverse ways.
Wang J; Manley JL
RNA; 1995 May; 1(3):335-46. PubMed ID: 7489505
[TBL] [Abstract][Full Text] [Related]
31. The [U4/U6.U5] tri-snRNP-specific 27K protein is a novel SR protein that can be phosphorylated by the snRNP-associated protein kinase.
Fetzer S; Lauber J; Will CL; Lührmann R
RNA; 1997 Apr; 3(4):344-55. PubMed ID: 9085842
[TBL] [Abstract][Full Text] [Related]
32. Protein-protein interactions and 5'-splice-site recognition in mammalian mRNA precursors.
Kohtz JD; Jamison SF; Will CL; Zuo P; Lührmann R; Garcia-Blanco MA; Manley JL
Nature; 1994 Mar; 368(6467):119-24. PubMed ID: 8139654
[TBL] [Abstract][Full Text] [Related]
33. Multiple activities of the human splicing factor ASF.
Harper JE; Manley JL
Gene Expr; 1992; 2(1):19-29. PubMed ID: 1535526
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of RNA splicing at the Rous sarcoma virus src 3' splice site is mediated by an interaction between a negative cis element and a chicken embryo fibroblast nuclear factor.
Amendt BA; Simpson SB; Stoltzfus CM
J Virol; 1995 Aug; 69(8):5068-76. PubMed ID: 7609076
[TBL] [Abstract][Full Text] [Related]
35. The SR splicing factors ASF/SF2 and SC35 have antagonistic effects on intronic enhancer-dependent splicing of the beta-tropomyosin alternative exon 6A.
Gallego ME; Gattoni R; Stévenin J; Marie J; Expert-Bezançon A
EMBO J; 1997 Apr; 16(7):1772-84. PubMed ID: 9130721
[TBL] [Abstract][Full Text] [Related]
36. A splicing enhancer in the E4 coding region of human papillomavirus type 16 is required for early mRNA splicing and polyadenylation as well as inhibition of premature late gene expression.
Rush M; Zhao X; Schwartz S
J Virol; 2005 Sep; 79(18):12002-15. PubMed ID: 16140776
[TBL] [Abstract][Full Text] [Related]
37. A 57-nucleotide upstream early polyadenylation element in human papillomavirus type 16 interacts with hFip1, CstF-64, hnRNP C1/C2, and polypyrimidine tract binding protein.
Zhao X; Oberg D; Rush M; Fay J; Lambkin H; Schwartz S
J Virol; 2005 Apr; 79(7):4270-88. PubMed ID: 15767428
[TBL] [Abstract][Full Text] [Related]
38. Deletion of the N-terminus of SF2/ASF permits RS-domain-independent pre-mRNA splicing.
Shaw SD; Chakrabarti S; Ghosh G; Krainer AR
PLoS One; 2007 Sep; 2(9):e854. PubMed ID: 17786225
[TBL] [Abstract][Full Text] [Related]
39. Utilization of splicing elements and polyadenylation signal elements in the coupling of polyadenylation and last-intron removal.
Cooke C; Hans H; Alwine JC
Mol Cell Biol; 1999 Jul; 19(7):4971-9. PubMed ID: 10373547
[TBL] [Abstract][Full Text] [Related]
40. The adenovirus E4-ORF4 splicing enhancer protein interacts with a subset of phosphorylated SR proteins.
Estmer Nilsson C; Petersen-Mahrt S; Durot C; Shtrichman R; Krainer AR; Kleinberger T; Akusjärvi G
EMBO J; 2001 Feb; 20(4):864-71. PubMed ID: 11179230
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
